DOC News Track the topics, authors and articles important to you
HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
 QUICK SEARCH:   [advanced]


     


DOC News    October 1, 2005
Volume 2 Number 10 p. 12
© 2005 American Diabetes Association

Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stimulation No Shortcut to Fitness

Electrical stimulation of muscle by way of electrodes on the skin issometimes helpful for people with neurological injury or disease, mimickingexercise sufficiently to increase measures of fitness and glucose metabolism.It makes sense to hypothesize that such an approach might help peoplestruggling with diabetes and obesity when exercise presents greatdifficulties.

It comes as no shock to learn that while electrical muscle stimulation(EMS) is exercise-like in the near term, the benefits are too small to beclinically meaningful for people with type 2 diabetes. You can't just twitchyour way to fitness, suggests a clinical study by a group of researchers atUniversity of Southampton, U.K.

Investigators tested EMS on 33 healthy volunteers—16 men and 17 womenaged 21–55 years. The study included five people with type 2 diabetes46–51 years of age. Each participant used EMS for up to 4 hours dailyfor 12 weeks. In the near term, EMS increased pulse rate, blood pressure,energy expenditure, and glucose uptake.

However, at the end of the study period, there was no difference in bodycomposition or clinical parameters. The "magnitude of this change is toosmall to have any clinical benefit," the researchers conclude.

Poole RB, Harrold CP, Burridge JH, et al.: Electricalmuscle stimulation acutely mimics exercise in neurologically intactindividuals but has limited clinical benefits in patients with type 2diabetes. Diabetes Obes Metab 7: 344–351, 2005.[Medline]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
DOC News Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum